Statistics
Publications
2
Citations
113
H-Index
2
Active since
2024
Affiliations
Heng Lin is an author at University of Michigan specializing in immune checkpoint inhibitor therapy, oncology, and medicine.
Publications per year
2024–2024
2
2
Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance
Heng Lin, Kole Tison, Yuheng Du et al. · Cancer Cell · 2024 · 83 citations · Full text
Medicine, Immunology, Oncology +17
PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages
Michael Pitter, Ilona Kryczek, Hongjuan Zhang et al. · Cell Reports · 2024 · 30 citations · Full text
Medicine, Immunology, Oncology +17
1–2 of 2